Persist AI raises $12M in Series A funding to launch its Cloud Lab for accelerating pharmaceutical formulation development, led by Spero Ventures.
PRIVATEMay 19, 2025
Amount Raised
$12 Million
Round Type
Series A
West SacramentoManufacturingBiotechnologyHealth CareArtificial IntelligencePharmaceutical
Investors
YCombinatorCartography CapitalGood Ai CapitalPurdue VenturesFord Street CapitalSignalFireMbx CapitalShimadzu Future Innovation Fund Managed By Global Brain CorporationEli Lilly & CompanyAsymmetry Ventures2048 VenturesInnosparkY CombinatorSpero Ventures
Description
Persist AI announced the launch of its Cloud Lab platform after raising $12 million in an oversubscribed Series A financing round. The platform enables pharmaceutical companies to accelerate drug formulation development using advanced robotics. This funding round was led by Spero Ventures, alongside multiple other investors. The investment aims to lower the hurdles in developing next-generation therapeutics.
Company Information
Company
Persist AI
Location
890 Embarcadero Dr.
West Sacramento, California, United States
About
Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023.
Fundz sees it the moment Persist AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
West SacramentoManufacturingBiotechnologyHealth CareArtificial IntelligencePharmaceutical